PC
CBST

PointState Capital’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

PointState Capital’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,650,000
Closed -$109M – 148
2014
Q3 		$109M Buy
1,650,000
+930,000
+129% +$61.1M 1.98% 16
2014
Q2 		$50.3M Sell
720,000
-280,000
-28% -$19M 0.63% 32
2014
Q1 		$73.2M Buy
1,000,000
+160,825
+19% +$12M 1.16% 24
2013
Q4 		$57.8M Buy
839,175
+64,175
+8% +$4.15M 0.73% 37
2013
Q3 		$49.3M Sell
775,000
-325,000
-30% -$19.6M 0.84% 30
2013
Q2 		$53.1M Buy
+1,100,000
New +$54.1M 0.91% 26

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PointState Capital's CBST Position: Q4 2014 in Review

PointState Capital sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 1,650,000 shares — an estimated $109M sold.

PointState Capital first reported a position in CBST in Q2 2013 and held it in 6 quarters. The position peaked at $109M in Q3 2014. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • PointState Capital reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • PointState Capital sold 1,650,000 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $109M.
  • PointState Capital first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • PointState Capital's CUBIST PHARMACEUTICALS INC position peaked at $109M in Q3 2014.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on PointState Capital's 13F filing for Q4 2014, filed 17 Feb 2015.